Market snapshot: US markets regain some poise
President Trump has raised the tariff on India to 50%, while Apple is investing a $100 billion in the US. In the UK, the Bank of England is widely expected to cut interest rates later today, writes head of markets Richard Hunter.
7th August 2025 08:31
by Richard Hunter from interactive investor
US markets regained some poise after a troubling few trading sessions, with most company results continuing to shore up recent gains.
- Invest with ii: SIPP Account | Stocks & Shares ISA | See all Investment Accounts
An estimated 80% of corporates in the earnings season so far have surpassed expectations, removing some of the valuation concerns which had resulted from the main indices trading at record highs. The latest beneficiaries were McDonald's Corp (NYSE:MCD), which beat on earnings and profits, while the wider indices were boosted by a 5% jump in Apple Inc (NASDAQ:AAPL) shares after the White House confirmed that the group would be upping its domestic manufacturing investment by a further $100 billion (£74 billion), taking the cumulative total to some $600 billion.
At the same time, earnings misses continue to be punished amid the fragile sentiment, as the likes of Snap Inc Class A (NYSE:SNAP), Advanced Micro Devices Inc (NASDAQ:AMD) and The Walt Disney Co (NYSE:DIS) found to their cost.
Tariff threats and trauma have become a way of investing life of late, such that the latest announcements had limited effect. President Donald Trump doubled the tariffs on India to 50% given its purchases of Russian oil, while also promising a 100% levy on all imported chips, exempting those companies which manufacture in the US.
More broadly, investors are now looking for a catalyst to rekindle the animal spirits which had significantly boosted markets. More recent economic data has shown definite signs of weakening, especially within the labour market, which has apparently opened the door to a Federal Reserve rate cut in September, even though the central bank remains committed to judging inflationary tariff effects before easing.
In the meantime, the main indices remain in rude health for the year to date, with gains of 3.9%, 7.9% and 9.6% for the Dow Jones, S&P 500 and Nasdaq respectively.
Asian markets were mixed to positive, but China made its own statement of intent as its fractious relationship with the US rumbles on. Exports expanded by 7.2% in July overall, which came despite a 6.1% decline in exports to the US, its largest trading partner. China’s trade surplus fell as a result to $98 billion from $115 billion the previous month, but the numbers nonetheless show a resilience regardless of the current trade negotiations.
A significant technical overhang weighed on the premier index at the open, as a dozen companies traded ex-dividend, including heavyweights such as AstraZeneca (LSE:AZN), Barclays (LSE:BARC), NatWest Group (LSE:NWG), BT Group (LSE:BT.A), Rolls-Royce Holdings (LSE:RR.) and Reckitt Benckiser Group (LSE:RKT).
Hikma Pharmaceuticals (LSE:HIK) shares slumped after a disappointing interim update, which adds to the pressure which the pharmaceutical sector has been facing of late, not least of which is due to the various tariff threats emanating from the US.
WPP (LSE:WPP) can currently do little right in the eyes of investors at the moment, with its half-year numbers failing to impress, with a drop in opening exchanges leading to a decline of 53% in the share price this year alone.
InterContinental Hotels Group (LSE:IHG) offered some scant relief after sailing past revenue expectations, with a 6% hike in the price following. Despite the general limitations, the FTSE 100 remains up by 11.8% in the year to date, continuing to flex its muscles as an attractive investment destination.
The Bank of England is widely expected to cut interest rates later today by 0.25% to 4%, although how much of an impact it will have on an unstable UK economy is moot. On the one hand, there are sufficient emerging signs of weakness which invite the need for stimulus, although inflation remains a nagging concern. Of equal interest to the decision itself will be the accompanying comments, which may reveal the bank’s latest guidance on the likelihood of any further cuts to come as the economy continues to flounder.
These articles are provided for information purposes only. Occasionally, an opinion about whether to buy or sell a specific investment may be provided by third parties. The content is not intended to be a personal recommendation to buy or sell any financial instrument or product, or to adopt any investment strategy as it is not provided based on an assessment of your investing knowledge and experience, your financial situation or your investment objectives. The value of your investments, and the income derived from them, may go down as well as up. You may not get back all the money that you invest. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment adviser.
Full performance can be found on the company or index summary page on the interactive investor website. Simply click on the company's or index name highlighted in the article.